Insulin delivery company Insulet Corporation (NASDAQ:PODD) will be announcing earnings results tomorrow after market close. Here’s what to expect. Insulet beat analysts’ revenue expectations ...

It might be of some concern to shareholders to see the Insulet Corporation (NASDAQ:PODD) share price down 11% in the last month. But the silver lining is the stock is up over five years.

Investors in Insulet Corp (Symbol: PODD) saw new options begin trading this week, for the April 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the PODD ...

Stifel Nicolaus analyst Mathew Blackman maintained a Hold rating on Insulet (PODD – Research Report) today and set a price target of $293.00. The company’s shares closed yesterday at $288.29.

The firm increased its portfolio allocation in PODD by 6.31% over the last quarter. AMCPX - AMCAP FUND holds 3,225K shares representing 4.59% ownership of the company. In its prior filing ...

NASDAQ:PODD opened at $279.55 on Thursday. Insulet has a 12-month low of $160.19 and a 12-month high of $289.46. The firm has a market capitalization of $19.61 billion, a P/E ratio of 47.87 ...

Insulet stock opened at $270.81 on Tuesday. The company has a debt-to-equity ratio of 1.21, a quick ratio of 2.80 and a current ratio of 3.68. The firm has a market cap of $19.02 billion, a P/E ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Insulet (PODD – Research Report), Prothena (PRTA – Research Report) and Travere Therapeutics (TVTX ...

At CES 2025, I had the opportunity to see firsthand the technological innovations that are shaping the future of the automotive industry. Any long-term attendee of CES can attest that its role as ...

Flashback är för miljontals svenskar en lika självklar informationskanal som traditionella medier. Under masskjutningen i Örebro blev det tydligt hur Flashbackkroppen kan fungera. Det ...